Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in patients on hemodialysis

Heart and Vessels

Volumn 28, Issue 3, 2013, Pages 308-315

  Yano, Hideki ^a   Horinaka, Shigeo ^a   Yagi, Hiroshi ^a   Ishimitsu, Toshihiko ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

C reactive protein; Hemodialysis; Interleukin 6; Major adverse cardiac event; Paclitaxel eluting stent

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CREATINE KINASE; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEOPTERIN; NICORANDIL; PACLITAXEL; RAPAMYCIN; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE HEART INFARCTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HEART DEATH; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IN-STENT RESTENOSIS; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SILENT MYOCARDIAL ISCHEMIA; STABLE ANGINA PECTORIS; STENT THROMBOSIS; UNSTABLE ANGINA PECTORIS;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MALE; MIDDLE AGED; PACLITAXEL; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS DESIGN; RENAL DIALYSIS; RISK FACTORS; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84878724879     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-012-0250-9     Document Type: Article

References (37)

1. Cheung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, Kaufman A, Lewis J, Rocco M, Toto R, Windus D, Ornt D, Levey AS, HEMO Study Group (2004) Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int 65:2380-2389
2. Herzog CA, Ma JZ, Collins AJ (2002) Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 106:2207-2211
3. Gruberg L, Dangas G, Mehran R, Mintz GS, Kent KM, Pichard AD, Satler LF, Lansky AJ, Stone GW, Leon MB (2002) Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter Cardiovasc Interv 55:66-72
4. Das P, Moliterno DJ, Charnigo R, Mukherjee D, Steinhubl SR, Sneed JD, Booth DC, Ziada KM (2006) Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. J Invasive Cardiol 18:405-408
5. Yachi S, Tanabe K, Tanimoto S, Aoki J, Nakazawa G, Yamamoto H, Otsuki S, Yagishita A, Kishi S, Nakano M, Taniwaki M, Sasaki S, Nakajima H, Mise N, Sugimoto T, Hara K (2009) Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients. Am J Kidney Dis 54:299-306
6. Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H (2006) Clinical outcomes following percutaneous coronary intervention with drug-eluting vs bare-metal stents in dialysis patients. J Invasive Cardiol 18:577-583
7. Kim JY, Ko YG, Shim CY, Park S, Hwang KC, Choi D, Jang Y, Chung N, Shim WH, Cho SY (2005) Comparison of effects of drug-eluting stent versus bare metal stents on plasma C-reactive protein levels. Am J Cardiol 96:1384-1388
8. Ozer N, Tangurek B, Firat F, Ozer S, Tartan Z, Ozturk R, Ozay B, Ciloglu F, Yilmaz H, Cam N (2008) Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention. Heart Vessels 23:75-82
9. Windecker S, Remondino A, Eberli FR, Jüni P, Räber L, Wenaweser P, Togni M, Billinger M, Tüller D, Seiler C, Roffi M, Corti R, Sütsch G, Maier W, Lüscher T, Hess OM, Egger M, Meier B (2005) Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 353:653-662
10. Morice MC, Colombo A, Meier B, Serruys P, Tamburino C, Guagliumi G, Sousa E, Stoll HP, REALITY Trial Investigators (2006) Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA 295:895-904
11. Pires NM, Eefting D, de Vries MR, Quax PH, Jukema JW (2007) Sirolimus and paclitaxel provoked different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries. Heart 93:922-927
12. Kang WC, Ahn TH, Moon CI, Han SH, Shin EK, Kim JS, Ko YG, Choi D, Jang Y, Kim BK, Oh SJ, Jeon DW, Yang JY (2009) Comparison of inflammatory markers and angiographic outcomes after implantation of sirolimus and paclitaxel-eluting stents. Heart 95:970-975
13. Li JJ, Zhang YP, Wang C, Gao LJ, Qin XW, Xu B, Chen JL, Yang YJ, Gao RL (2009) Impact of direct sirolimus-eluting stent implantation on the early systemic inflammatory response compared with complementary stent implantation. Coron Artery Dis 20:65-70
14. Gaspardone A, Versaci F (2005) Coronary stenting and inflammation. Am J Cardiol 96:65L-70L
15. Versaci F, Gaspardone A (2004) Prevention of restenosis after stenting: the emerging role of inflammation. Coron Artery Dis 15:307-311
16. Cirillo P, Golino P, Calabrò P, Calì G, Ragni M, De Rosa S, Cimmino G, Pacileo M, De Palma R, Forte L, Gargiulo A, Corigliano FG, Angri V, Spagnuolo R, Nitsch L, Chiariello M (2005) C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovasc Res 68:47-55
17. Li JJ, Li J, Nan JL, Li Z, Zhen X, Mu CW, Dai J, Zhang CY (2007) Coronary restenotic reduction of drug-eluting stent may be due to its anti-inflammatory effects. Med Hypotheses 69:1004-1009
18. Yazdani S, Simon AD, Vidhun R, Gulotta C, Schwartz A, Rabbani LE (1998) Inflammatory profile in unstable angina versus stable angina in patients undergoing percutaneous interventions. Am Heart J 136:357-361
19. Ferrante G, Niccoli G, Biasucci LM, Liuzzo G, Burzotta F, Galiuto L, Trani C, Rebuzzi AG, Crea F (2008) Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients. Cardiovasc Revasc Med 9:156-165
20. Toutouzas K, Colombo A, Stefanadis C (2004) Inflammation and restenosis after percutaneous coronary interventions. Eur Heart J 25:1679-1687
21. Pasceri V, Willerson JT, Yeh ET (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102:2165-2168
22. Niccoli G, Montone RA, Ferrante G, Crea F (2010) The evolving role of inflammatory biomarkers in risk assessment after stent implantation. J Am Coll Cardiol 56:1783-1793
23. Yano H, Horinaka S, Iemura T, Ishimura K, Yagi H, Yabe A, Ishimitsu T (2011) Comparison of the chronic anti-inflammation effects after implantation of drug eluting stent and bare metal stent. Shinzo 43:1319-1327 (in Japanese)
24. Otsuka M, Toyofuku M, Watanabe N, Motoda C, Kawase T, Takeda R, Mito S, Tamekiyo H, Okimoto T, Hirao H, Muraoka Y, Ueda H, Masaoka Y, Hayashi Y (2011) Clinical usefulness of drug-eluting stents in the treatment of dialysis patients with coronary artery disease. EuroIntervention 6:754-759
25. Higashitani M, Mori F, Yamada N, Arashi H, Kojika A, Hoshi H, Minami Y, Yamaguchi J, Yamauchi T, Takagi A, Ogawa H, Hagiwara N (2011) Efficacy of paclitaxel-eluting stent implantation in hemodialysis patients. Heart Vessels 26:582-589
26. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM (2002) Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39:695-701
27. Bocksch W, Fateh-Moghadam S, Mueller E, Huehns S, Waigand J, Dietz R (2005) Percutaneous coronary intervention in patients with end-stage renal disease. Kidney Blood Press Res 28:275-279
28. Fujii K, Mintz GS, Kobayashi Y, Carlier SG, Takebayashi H, Yasuda T, Moussa I, Dangas G, Mehran R, Lansky AJ, Reyes A, Kreps E, Collins M, Colombo A, Stone GW, Teirstein PS, Leon MB, Moses JW (2004) Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation 109:1085-1088
29. Kuriyama N, Kobayashi Y, Nakayama T, Kuroda N, Komuro I (2006) Images in cardiovascular medicine. Damage to polymer of a sirolimus-eluting stent. Circulation 114:e586-e587
30. Tamekiyo H, Hayashi Y, Toyofuku M, Ueda H, Sakuma T, Okimoto T, Otsuka M, Imazu M, Kihara Y (2009) Clinical outcomes of sirolimus-eluting stenting after rotational atherectomy. Circ J 73:2042-2049
31. Aoyama T, Ishii H, Toriyama T, Takahashi H, Kasuga H, Murakami R, Amano T, Uetani T, Yasuda Y, Yuzawa Y, Maruyama S, Matsuo S, Matsubara T, Murohara T (2008) Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J 72:56-60
32. Moussa I, Ellis SG, Jones M, Kereiakes DJ, McMartin D, Rutherford B, Mehran R, Collins M, Leon MB, Popma JJ, Russell ME, Stone GW (2005) Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study). Am J Cardiol 96:1242-1247
33. London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transpl 18:1731-1740
34. Levin AD, Vukmirovic N, Hwang CW, Edelman ER (2004) Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel. Proc Natl Acad Sci USA 101:9463-9467
35. Patterson C, Mapera S, Li HH, Madamanchi N, Hilliard E, Lineberger R, Herrmann R, Charles P (2006) Comparative effects of paclitaxel and rapamycin on smooth muscle migration and survival: role of AKT-dependent signaling. Arterioscler Thromb Vasc Biol 26:1473-1480
36. Luc G, Arveiler D, Evans A, Amouyel P, Ferrieres J, Bard JM, Elkhalil L, Fruchart JC, Ducimetiere P, PRIME Study Group (2003) Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study. Atherosclerosis 170:169-176
37. Adachi T, Naruko T, Itoh A, Komatsu R, Abe Y, Shirai N, Yamashita H, Ehara S, Nakagawa M, Kitabayashi C, Ikura Y, Ohsawa M, Yoshiyama M, Haze K, Ueda M (2007) Neopterin is associated with plaque inflammation and destabilisation in human coronary atherosclerotic lesions. Heart 93:1537-1541